Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phathom Pharmaceuticals (PHAT) Other Non-Current Liabilities (2021 - 2026)

Phathom Pharmaceuticals has reported Other Non-Current Liabilities over the past 6 years, most recently at $3.5 million for Q1 2026.

  • Quarterly Other Non-Current Liabilities fell 69.57% to $3.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.5 million through Mar 2026, down 69.57% year-over-year, with the annual reading at $4.0 million for FY2025, 65.22% down from the prior year.
  • Other Non-Current Liabilities was $3.5 million for Q1 2026 at Phathom Pharmaceuticals, down from $4.0 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $11.5 million in Q4 2024 and troughed at $3.5 million in Q1 2026.
  • The 5-year median for Other Non-Current Liabilities is $7.5 million (2022), against an average of $8.6 million.
  • Year-over-year, Other Non-Current Liabilities skyrocketed 43.33% in 2024 and then plummeted 69.57% in 2026.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $7.5 million in 2022, then increased by 29.33% to $9.7 million in 2023, then rose by 18.56% to $11.5 million in 2024, then tumbled by 65.22% to $4.0 million in 2025, then fell by 12.5% to $3.5 million in 2026.
  • Per Business Quant, the three most recent readings for PHAT's Other Non-Current Liabilities are $3.5 million (Q1 2026), $4.0 million (Q4 2025), and $11.5 million (Q3 2025).